Related Experiment Videos
Communicating genetic risk: pros, cons, and counsel
R T Penson1, M V Seiden, K M Shannon
1Hematology-Oncology Department, Massachusetts General Hospital, Boston, Massachusetts, USA. rpenson@partners.org
The Oncologist
|May 5, 2000
Summary
This case study explores genetic testing for BRCA1 and BRCA2 mutations in a woman with a strong family history of breast cancer. It highlights challenges in genetic information ownership, risk communication, and emotional support for patients and families.
Area of Science:
- Oncology
- Genetics
- Bioethics
Background:
- The Kenneth B. Schwartz Center at Massachusetts General Hospital (MGH) supports compassionate healthcare delivery.
- Schwartz Center Rounds facilitate multidisciplinary discussions on psychosocial issues in patient care.
Observation:
- A woman with personal and family history of breast cancer considered BRCA1/BRCA2 genetic testing.
- Patient anxiety and provider disagreement complicated the decision-making process.
- The case presented ethical dilemmas regarding genetic information ownership and dissemination.
Findings:
- Difficulties in communicating genetic risk and providing emotional support were identified.
- Uncertainties surrounding screening and intervention strategies for BRCA1/BRCA2 mutations were reviewed.
- The molecular biology, inheritance, and epidemiology of BRCA1 and BRCA2 genes were discussed.
Implications:
- This case underscores the complex psychosocial and ethical considerations in genetic cancer risk assessment.
- Effective communication strategies and support systems are crucial for patients undergoing genetic testing.
- Understanding the nuances of genetic information is vital for informed healthcare decisions and family counseling.
Keywords:
Genetics and Reproduction